Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20385221)

  • 1. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
    Li F; Weng Y; Wang L; He H; Yang J; Tang X
    Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved antitumor efficacy and reduced toxicity of liposomes containing bufadienolides.
    Hu K; Zhu L; Liang H; Hu F; Feng J
    Arch Pharm Res; 2011 Sep; 34(9):1487-94. PubMed ID: 21975810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bufadienolide-loaded submicron emulsion for oral administration: stability, antitumor efficacy and toxicity.
    Li W; Lin X; Yang Z; Zhang W; Ren T; Qu F; Wang Y; Zhang N; Tang X
    Int J Pharm; 2015 Feb; 479(1):52-62. PubMed ID: 25545797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers.
    Li F; Wang Y; Liu Z; Lin X; He H; Tang X
    Drug Dev Ind Pharm; 2010 May; 36(5):508-17. PubMed ID: 19821716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.
    Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q
    Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
    Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
    Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D; Liu Z; Wang L; Zhang C; Zhang N
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
    Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N
    Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
    Baek JS; Pham CV; Myung CS; Cho CW
    Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface density of polyarginine influence the size, zeta potential, cellular uptake and tissue distribution of the nanostructured lipid carrier.
    Sun M; Zhu Z; Wang H; Han C; Liu D; Tian L; Yang X; Pan W
    Drug Deliv; 2017 Nov; 24(1):519-526. PubMed ID: 28181841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen nanostructured lipid carriers: enhanced in vivo antitumor efficacy with reduced adverse drug effects.
    Shete HK; Selkar N; Vanage GR; Patravale VB
    Int J Pharm; 2014 Jul; 468(1-2):1-14. PubMed ID: 24704438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice.
    Zhang XY; Qiao H; Ni JM; Shi YB; Qiang Y
    Eur J Pharm Sci; 2013 Jun; 49(3):411-22. PubMed ID: 23624327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel.
    Sun B; Luo C; Li L; Wang M; Du Y; Di D; Zhang D; Ren G; Pan X; Fu Q; Sun J; He Z
    Colloids Surf B Biointerfaces; 2016 Jul; 143():47-55. PubMed ID: 27011346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies.
    Shete H; Chatterjee S; De A; Patravale V
    Int J Pharm; 2013 Sep; 454(1):584-92. PubMed ID: 23535344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
    Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
    Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells.
    Zhang XG; Miao J; Dai YQ; Du YZ; Yuan H; Hu FQ
    Int J Pharm; 2008 Sep; 361(1-2):239-44. PubMed ID: 18586075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine.
    Li S; Ji Z; Zou M; Nie X; Shi Y; Cheng G
    AAPS PharmSciTech; 2011 Sep; 12(3):1011-8. PubMed ID: 21811889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.